Combination therapy in patients with atherosclerotic cardiovascular disease

被引：0
|
作者：
Laffman-Johnson, Elise
机构：
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2012年 / 91卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：159 / 159
页数：1
相关论文
共 50 条
  • [41] Diabetes associated residual atherosclerotic cardiovascular risk in statin-treated patients with prior atherosclerotic cardiovascular disease
    Zhao, Yanglu
    Xiang, Pin
    Coll, Blai
    Lopez, J. Antonio G.
    Wong, Nathan D.
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2021, 35 (03)
  • [42] Periodontal disease and atherosclerotic cardiovascular disease
    Berent, Robert
    Sinzinger, Helmut
    VASA-EUROPEAN JOURNAL OF VASCULAR MEDICINE, 2013, 42 (01) : 3 - 7
  • [43] Anti-inflammatory therapy in atherosclerotic cardiovascular disease: Current reappraisal
    Muduli, Subrat
    Gupta, Mohit D.
    Girish, M. P.
    Yadav, Rakesh
    INDIAN HEART JOURNAL, 2023, 75 (06) : 391 - 397
  • [44] Underprescribing of statin therapy in people with HIV at risk for atherosclerotic cardiovascular disease
    Aragon, Kelsea Gallegos
    Ray, Gretchen
    Conklin, Jessica
    Stever, Erin
    Marquez, Carlos
    Magallanes, Adan
    Anderson, Joe
    Jakeman, Bernadette
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2022, 79 (22) : 2026 - 2031
  • [45] Medical therapy for atherosclerotic cardiovascular disease in patients with myocardial injury after non-cardiac surgery
    Chen, Jin F.
    Smilowitz, Nathaniel R.
    Kim, Jung T.
    Cuff, Germaine
    Boltunova, Alina
    Toffey, Jason
    Berger, Jeffrey S.
    Rosenberg, Andrew
    Kendale, Samir
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2019, 279 : 1 - 5
  • [46] Management of mixed dyslipidemia in patients with or at risk for cardiovascular disease: A role for combination fibrate therapy
    Fazio, Sergio
    CLINICAL THERAPEUTICS, 2008, 30 (02) : 294 - 306
  • [47] Combination Therapy to Prevent Cardiovascular Disease Slow Progress
    Smith, Richard
    McCready, Tara
    Yusuf, Salim
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2013, 309 (15): : 1595 - 1596
  • [48] Therapy in patients at high risk for atherosclerotic cardiovascular disease -: From biological efficacy to disappointing clinical outcomes
    Fainaru, M
    FREE RADICAL BIOLOGY AND MEDICINE, 2002, 33 : S186 - S186
  • [49] Choice of initial treatment with cholesterol lowering drugs in patients with familial hypercholesterolemia, atherosclerotic cardiovascular disease, or increased risk of atherosclerotic cardiovascular disease
    Hoe, Jakob Kronkvist
    Jensen, Camilla B.
    Hansen, Susanne
    Olsen, Rasmus Huan
    Johansen, Tina
    Jimenez-Solem, Espen
    Petersen, Janne
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 : 178 - 179
  • [50] Hypothyroidism and Atherosclerotic Cardiovascular Disease
    Kannan, Lakshmi
    Chernoff, Arthur
    ENDOCRINE REVIEWS, 2014, 35 (03)
12345